on OXURION (EBR:OXUR)
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
On July 23, 2025, Oxurion NV, a biopharmaceutical company based in Leuven, Belgium and listed on Euronext Brussels, received a transparency notification. Under Belgian law, Atlas Special Opportunities II LLC held, as of July 21, 2025, 1,845,939 shares out of a total of 12,428,021, representing less than 15% of the capital. This decrease resulted from the sale of securities conferring voting rights.
Oxurion focuses on therapeutic innovation and the application of advanced technologies to clinical research. The company aims to accelerate and secure the development of new treatments.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news